FolioLanternBeta
UTHRUnited Therapeutics Corp

Christopher Causey

Director at United Therapeutics Corp, as of Jul 23, 2026Sold $2.3M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
4.3K
shares sold, past 12 months
5
days with sales
$786K
largest single day, Mar 30, 2026
1
company filed for

Share of stake sold and shares held at United Therapeutics Corp are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $1.0M under a disclosed plan$1.0MJanFeb 2026: $520K under a disclosed planFebMar 2026: $796K under a disclosed planMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
United Therapeutics Corp (UTHR)DirectorJun 28, 2004Jul 23, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.